Accuray Incorporated (ARAY) is scheduled to report 4th quarter earnings on 08/09/2023.
Regarding Q4 estimates, Wall Street analysts expect Accuray Incorporated to post earnings of $0.01 per share. Revenue expectations are pegged at $121.75 million. Last quarter, Accuray Incorporated beat earnings estimates, reporting EPS of $0.01 on estimates of -$0.01. The stock rose by 17.41% the day after the last earnings release.
Year-to-date, ARAY stock has risen by 102.90%.
About Accuray Incorporated
Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.
Stay up-to-date on earnings this week, with TipRanks’ Earnings Calendar.
